Valuation: BOIRON

Market Cap 477M 546M 439M 409M 776M 52B 788M 5.27B 2.05B 25.56B 2.05B 2.01B 88.09B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 430M 491M 395M 368M 698M 46.79B 709M 4.74B 1.84B 23B 1.84B 1.81B 79.26B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.36%
1 week-2.48%
Current month-0.72%
1 month+1.48%
3 months-1.79%
6 months-8.64%
Current year-9.24%
1 week 27.5
Extreme 27.5
28.1
1 month 27.1
Extreme 27.1
29
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap.
23-10-28Sell

Director

198,664 1.1323%
23-10-28Sell

Director

3,267,121 18.6209%
23-10-28Sell

Director

3,267,121 18.6209%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-2.48%+22.49%-30.38% 546M
+0.21%+3.96%-12.47%-7.71% 12.84B
+0.34%+4.33%-34.57%-57.93% 4.72B
+2.23%+12.59%+17.91%-6.37% 3.91B
+1.10%+6.55%+4.13%-39.43% 3.84B
+0.13%-11.54%-14.01%-20.23% 3.05B
+1.74%+5.74%-11.17%-1.48% 3.08B
+0.79%+6.47%-7.22%-25.40% 2.38B
+0.53%+7.02%-14.09%+33.06% 1.72B
+2.59%+8.49%-11.64%-14.77% 1.69B
Average +0.93%-0.03%-6.06%-17.06% 3.78B
Weighted average by Cap. +0.79%+0.10%-9.61%-17.48%

Financials

2024 2025
Net sales 488M 558M 448M 418M 792M 53.1B 804M 5.38B 2.09B 26.1B 2.09B 2.05B 89.95B 501M 573M 461M 429M 814M 54.58B 827M 5.53B 2.15B 26.83B 2.15B 2.11B 92.45B
Net income 11.34M 12.97M 10.42M 9.71M 18.42M 1.23B 18.7M 125M 48.62M 607M 48.67M 47.63M 2.09B 32.64M 37.34M 30M 27.96M 53.04M 3.56B 53.84M 360M 140M 1.75B 140M 137M 6.02B
Net Debt -49.74M -56.9M -45.71M -42.61M -80.81M -5.42B -82.04M -549M -213M -2.66B -214M -209M -9.18B -47.86M -54.74M -43.98M -40.99M -77.75M -5.21B -78.93M -528M -205M -2.56B -205M -201M -8.83B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
26-07-03 €27.50 -0.36% 2,276
26-07-02 €27.60 0.00% 827
26-07-01 €27.60 -0.36% 772
26-06-30 €27.70 -1.07% 930
26-06-29 €28.00 -0.71% 529

Annual profits - Rate of surprise